Organization
Hospira, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Hospira, Inc.
... previously been identified through news reports and court filings. The labels confirm Hospira made the state’s vecuronium bromide, as the AP had identified last year. ...
... or intentions regarding the future, and our recently completed acquisition of the Hospira infusion systems business. These forward-looking statements are based on management's current expectations, ...
... previously been identified through news reports and court filings. The labels confirm Hospira made the state's vecuronium bromide, as the AP had identified last year. ...
... the global IV bags market include B.Braun Melsungen AG, Baxter international Inc., Hospira Inc., West Pharmaceutical Services Inc., Wipak Group, Technoflex S.A., Fresenius SE & ...
... Allergan Baxter and Laboratoire Aguettant Collaborate for PN Trace Elements Pfizer Acquires Hospira Amanta Healthcare Invests for Development of SteriPort Baxter Acquires Claris Injectables ICU ...
... Manufacturing Organization (CDMO), has entered into definite agreements to acquire the former Hospira Boulder (Colorado) high containment API site from Pfizer, Inc. The closing of ...
... leading biosimilar companies based in the US, Western Europe and Israel: · Hospira (Pfizer) · Mylan · Sandoz (Novartis) · STADA Arzneimittel · Teva Pharmaceutical ...
... happened in July 2015, when the FDA urged hospitals to stop using Hospira's Symbiq drug-infusion pump because security vulnerabilities could have allowed hackers to access ...
... Laboratories Inc., Mylan Pharmaceuticals Inc., Teva USA(Barr Laboratories), STADA Pharmaceuticals Inc, and HOSPIRA. Order a copy of this 2017 Methotrexate Sodium market research report athttp://www.reportsnreports.com/purchase.aspx?name=1176380. ...
... to increase their product portfolio. For instance, in 2015, Pfizer, Inc. acquired Hospira, a key player in biosimilars market. In 2016, oncology was the largest ...
... competitive landscape of the market with some of the key players being Hospira (Pfizer), Fresenius Kabi, Hikma, Sandoz (Novartis), Sagent, Sanofi and Baxter. Key Topics ...
... rejected Amgen Inc.'s appeal seeking to compel discovery from Pfizer Inc. unit Hospira involving a biosimilar of Epogen, a drug used to boost red-blood cells ...
... players such as Baxter International (U.S.), Schott AG (Germany), Terumo Corporation (U.S.), Hospira Inc. (U.S.), Sanofi SA (France) etc. The market players adopt some crucial ...
... of Revenues for Aenova, Baxter, Catalent, Famar, Fareva, LTS Lohmann, Nipro, Patheon/DPx, Pfizer/Hospira, Vetter and Others (includes corresponding Graph/Chart) Table 9: Worldwide Injectables Contract Manufacturing ...
... parenteral nutrition industry are B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Hospira Inc.; Qatar Pharma Factory; Pharmaceutical Solutions Industry; Kuwait Saudi Pharmaceutical Industries Co.; ...
... PharMEDium Services is conducting a limited, voluntary recall due to Hospira Inc.'s ("Hospira") June 15, 2017 recall announcement that microbial growth was detected during ...
... during surgery or mechanical ventilation. The secondary recall of product manufactured by Hospira Inc., a Pfizer company, and repacked by Fagron Sterile Services is due ...
... Houston ("Advanced Pharma") is conducting a limited, voluntary recall due to Hospira Inc.'s ("Hospira") June 15, 2017 recall announcement that microbial growth was detected during ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤